Anavex Life Sciences Corp. (FRA:12X1)
Germany · Delayed Price · Currency is EUR 3.146
-0.013 (-0.41%)
Last updated: Dec 1, 2025, 8:10 AM CET
Anavex Life Sciences Market Cap
Anavex Life Sciences has a market cap or net worth of €293.59 million as of December 1, 2025. Its market cap has decreased by -59.27% in one year.
Market Cap
293.59M
Enterprise Value
205.36M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.15
Market Cap Chart
Since April 13, 2006, Anavex Life Sciences's market cap has increased from 264.36K to 293.59M, an increase of 110,960.34%. That is a compound annual growth rate of 42.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 295.12M | -66.46% |
| Dec 31, 2024 | 879.86M | 27.26% |
| Dec 29, 2023 | 691.39M | 2.35% |
| Dec 30, 2022 | 675.51M | -41.72% |
| Dec 31, 2021 | 1.16B | 292.09% |
| Dec 31, 2020 | 295.61M | 128.22% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |